India to Philippines: Amlodipine Export Trade Route
India has recorded 597 verified shipments of Amlodipine exported to Philippines, representing a combined trade value of $21.1M USD. This corridor is served by 76 active Indian exporters, with an average shipment value of $35.4K USD. The leading Indian exporter is AJANTA PHARMA LIMITED, which accounts for 46% of total export value with 69 shipments worth $9.7M USD. On the buying side, UNILAB INC is the largest importer in Philippines with $9.1M USD in purchases. The top 3 suppliers — AJANTA PHARMA LIMITED, FORTCAPS LABORATORIES PRIVATE LIMITED, TORRENT PHARMACEUTICALS LIMITED — together control 65% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Philippines Amlodipine corridor is one of India's established pharmaceutical export routes, with 597 shipments documented worth a combined $21.1M USD. The route is dominated by AJANTA PHARMA LIMITED, which alone accounts for roughly 46% of all export value, reflecting the consolidated nature of India's amlodipine manufacturing sector.
Across 76 active suppliers, the average shipment value stands at $35.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with amlodipine's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 25 days port-to-port. The route has recorded an annual growth rate of 34.3%, placing it at rank #10 among India's top amlodipine export destinations globally.
On the import side, key buyers of Indian amlodipine in Philippines include UNILAB INC, NELPA LIFESCIENCES INC, TORRENT PHARMA PHILS INC and 95 others. UNILAB INC is the single largest importer with 57 shipments valued at $9.1M USD.
